首页> 外文期刊>Bone >Monitoring bone strontium levels of an osteoporotic subject due to self-administration of strontium citrate with a novel diagnostic tool, in vivo XRF: A case study
【24h】

Monitoring bone strontium levels of an osteoporotic subject due to self-administration of strontium citrate with a novel diagnostic tool, in vivo XRF: A case study

机译:用一种新型的诊断工具,体内XRF监测由于柠檬酸锶自用引起的骨质疏松受试者的骨锶水平:一个案例研究

获取原文
获取原文并翻译 | 示例
           

摘要

A previously developed in vivo X-ray fluorescence (IVXRF) I-125 based system was used to measure bone strontium levels non-invasively in an osteoporotic female volunteer. The volunteer was recruited in December 2008, as part of the Ryerson and McMaster University Strontium in Bone Research Study and measured at twice weekly, weekly and monthly intervals. Thirty minute measurements were taken at the finger and ankle bone sites, representing primarily cortical and trabecular bone, respectively and the strontium K-alpha X-ray peak at 14.16. keV was used in the analysis. Since the volunteer had no prior history of strontium based medications or supplementation, baseline natural strontium levels were obtained followed by a 24. h measurement of first intake of strontium citrate supplements (680. mg Sr/day). While the baseline levels of 0.38 ± 0.05 and 0.39 ± 0.10 for the finger and ankle, respectively, were on par with those previously reported in Caucasians among twenty-two healthy non-supplementing strontium individuals by our group, an increase began to be seen after 24. hrs of 0.62 ± 0.14 and 0.45 ± 0.12 for the finger and ankle, respectively. By 120. h, the increase was statistically significant at 0.68 ± 0.07 and 0.93 ± 0.05, respectively. Further increases occurred within an interval of 90-180. days, with the most recent, after 800. days, at the finger and ankle being 7 and 15 times higher than the initial baseline reading. The intriguing results show bone strontium incorporation and retention follow a pattern, suggesting strontium levels, at least in the ankle, do not plateau within two to three years and will continue to increase over time, as an individual takes strontium supplements. The ability of this IVXRF system to monitor and measure bone strontium levels over time provides a useful diagnostic tool to help gain insight into strontium bone kinetics.
机译:先前开发的基于体内X射线荧光(IVXRF)I-125的系统用于非侵入性地测量骨质疏松女性志愿者的骨锶水平。作为瑞尔森和麦克马斯特大学锶研究的一部分,该志愿者于2008年12月被招募,每周,每周和每月间隔两次。在手指和脚踝骨部位(分别代表皮质骨和小梁骨)以及锶K-alpha X射线峰值在14.16处进行了30分钟的测量。 keV用于分析。由于志愿者没有基于锶的药物或补充剂的既往史,因此获得基线自然锶含量,然后首次摄入柠檬酸锶补充剂(680. mg Sr /天)进行24小时测量。在我们的22名健康非补充锶患者中,手指和脚踝的基线水平分别为0.38±0.05和0.39±0.10,与先前在高加索人中报道的水平相当,手指和脚踝的24.小时分别为0.62±0.14和0.45±0.12。到120小时,统计学上显着的增加分别为0.68±0.07和0.93±0.05。在90-180的间隔内进一步增加。天,最近的一次是在800天后,手指和脚踝的高度是初始基线读数的7倍和15倍。有趣的结果表明,骨锶的掺入和保留遵循一种模式,表明锶水平,至少在脚踝处,在两到三年内不会达到稳定状态,并且随着时间的推移会继续增加,因为个体需要补充锶。该IVXRF系统具有随时间监视和测量骨锶水平的能力,提供了有用的诊断工具,可帮助您深入了解锶骨动力学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号